Women’s health company DySIS Medical touted a $11.3 million (£7.4 million) fundraising round in support of its diagnostic devices.
The Scotland-based medical device maker hopes to expand market reach in Europe and the U.S. for its DySIS colposcope, an imaging device that painlessly assesses the condition of the cervix. The device already has CE Mark as well as regulatory approval from the FDA.